This session convenes investors and life science leaders for a high-impact virtual discussion translating key announcements from the J.P. Morgan Chase Healthcare Conference into actionable market insights. Gain expert perspectives on capital flows, mergers & acquisitions, IPOs, innovation trends, and valuation outlooks shaping the life sciences landscape in 2026. Fees apply for non-members; complimentary access for members.